Personalized medicine in oncology, the potential role of nuclear medicine imaging

Affiliations

Editorial

Christophe Van de Wiele et al. Curr Pharm Des. 2014.

. 2014;20(14):2231-3.

doi: 10.2174/13816128113196660669.

¹ Department of Nuclear Medicine, University Hospital Ghent, De Pintelaan 185B, 9000 Ghent, Belgium. christophe.vandewiele@ugent.be.

No abstract available

Similar articles

Diagnostic imaging in oncology. Proceedings of a meeting. Naples, Italy, 28-30 April 1993.
[No authors listed] [No authors listed] Nucl Med Biol. 1994 Jul;21(5):681-792. Nucl Med Biol. 1994. PMID: 9289312 No abstract available.
Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF, Nunes RF, Coutinho AM, Zaniboni EC, Costa LB, Barbosa FG, Queiroz MA, Cerri GG, Buchpiguel CA. Gomes Marin JF, et al. Radiographics. 2020 Oct;40(6):1715-1740. doi: 10.1148/rg.2020200021. Radiographics. 2020. PMID: 33001789 Review.
Oncologic imaging: a guiding hand of personalized cancer care.
Hricak H. Hricak H. Radiology. 2011 Jun;259(3):633-40. doi: 10.1148/radiol.11110252. Epub 2011 Apr 14. Radiology. 2011. PMID: 21493796 No abstract available.
Radiopharmacology: recent developments in the field of radiopharmaceuticals.
Cutler CS. Cutler CS. Q J Nucl Med Mol Imaging. 2015 Sep;59(3):239-40. Q J Nucl Med Mol Imaging. 2015. PMID: 26404758 No abstract available.
Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.
Langbein T, Weber WA, Eiber M. Langbein T, et al. J Nucl Med. 2019 Sep;60(Suppl 2):13S-19S. doi: 10.2967/jnumed.118.220566. J Nucl Med. 2019. PMID: 31481583 Review.